CareDx (CDNA) General Counsel Jeffrey Novack Sells 2,688 Shares

What Happened Jeffrey Adam Novack, Secretary and General Counsel of CareDx, sold a total of 2,688 shares in open-market transactions on August 5, 2026, generating gross proceeds of approximately $124,349. The sales were reported in two lots: 2,188 shares at a weighted average price of $46.15 (proceeds $100,974) and 500 shares at a weighted average price of $46.75 (proceeds $23,375). These transactions are dispositions (sales), which are often routine; at least one of the reported sales was made under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-08-05; Form 4 filed: 2026-08-06 (timely filing).
• Lot 1: 2,188 shares sold at a weighted average price of $46.15 — price range reported $45.49 to $46.45 (footnote F2); proceeds $100,974.
• Lot 2: 500 shares sold at a weighted average price of $46.75 — price range reported $46.59 to $46.94 (footnote F3); proceeds $23,375.
• Total shares sold: 2,688; total proceeds: ~$124,349.
• At least one sale was effected pursuant to a Rule 10b5-1 trading plan adopted September 4, 2025 (footnote F1).
• The filing does not specify shares owned after the reported transactions in the provided data.

Context

• Sales under a 10b5-1 plan are pre-arranged and can be routine; they do not necessarily indicate the insider’s current view of the company. No exercises, gifts, or tax-withholding events were reported in this filing.